Skip to main content
University of Wisconsin–Madison
Waisman Center
Waisman Center
Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
  • Resources & Information Expand Collapse
    • Topical Hub Pages: autism, cerebral palsy, Down syndrome, Fragile X, iPS Cells
    • Families
    • Employees
    • Providers
    • Researchers
    • Visitors
    • Students and Trainees
  • Clinical Services Expand Collapse
    • Clinics Overview
    • Augmentative and Alternative Communication (AAC) Program
    • Autism Treatment Programs Overview
    • Community Ties
    • Community Ties Psychiatric Cinic
    • WIN: Wellness Inclusion Nursing
  • LEND / Training
  • IDDRC / Research Expand Collapse
    • IDDRC / Research Homepage
    • Principal Investigators
    • Laboratory Websites
    • Research Topics
    • Core Services
    • Scientific Cores Leadership
    • Affiliated Departments
    • Required Core Grant Acknowledgements
  • UCEDD Expand Collapse
    • UCEDD Home Page
    • Priority Areas
    • Programs
    • Resources/Products
    • Issue & Study Briefs
    • Educational Opportunities
  • Participate in Research Expand Collapse
    • About Waisman Center Research
    • Enroll in a Registry
    • Studies Currently Recruiting
    • Contact
  • Core Services Expand Collapse
    • Overview
    • Administrative Core
    • Brain Imaging Core
    • Clinical Translational Core
    • Data Science Core
    • IDD Models (Cellular and Molecular Neuroscience, hPSC Models, Rodent Models) Core
  • WECP
  • Biomanufacturing Expand Collapse
    • UW Researchers
    • External / Industry
  • About Us
  • News
  • Events
  • Give
  • Careers
  • People
  • Español
  1. Home
  2. Amyloid

Amyloid

Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome

Amyloid beta associations with connected speech in cognitively unimpaired adults

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome

Proper names from story recall are associated with beta-amyloid in cognitively unimpaired adults at risk for Alzheimer’s disease

Association of sleep with cognition and beta amyloid accumulation in adults with Down syndrome

Amyloid accumulation in Down syndrome measured with amyloid load

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer’s disease in adults with Down syndrome

Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age.

Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report.

Neuropathological correlates of amyloid PET imaging in Down syndrome.

  • Previous page
  • 1
  • You're on page 2
  • 3
  • Next page

Site footer content

University logo that links to main university website Part of the Universities of Wisconsin

Information For

  • Families
  • Visitors
  • Students and Trainees
  • Researchers
  • Employees
  • Providers
  • INTRANET

Stay Connected

  • Waisman Newsletter
  • Slide of the Week

Contact Us

  • 1500 Highland Ave
    Madison, WI 53705

    Business Office: 608.263.1656
    Clinics: 608-915-0680 *NEW Number as of 5/1/25
    Director's Office: 608.263.5940
    Media Inquiries: 608.263.5837

    HOURS OF OPERATION
    Monday – Friday
    7:45 AM - 4:30 PM
  • Map map marker
  • Email: info@waisman.wisc.edu
  • Phone: 608-263-1656
    • facebook
    • x twitter
    • youtube
    • instagram

Website feedback, questions or accessibility issues: webmaster@waisman.wisc.edu | Learn more about accessibility at UW–Madison.

This site was built using the UW Theme | Privacy Notice | © 2025 Board of Regents of the University of Wisconsin System.